CSIMarket
 


Perspective Therapeutics Inc   (CATX)
Other Ticker:  
 
 

CATX's Capital Expenditures Growth by Quarter and Year

Perspective Therapeutics Inc 's Capital Expenditures results by quarter and year




CATX Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 0.00 0.09 0.14 0.04
III Quarter September 0.23 0.03 0.10 0.04
II Quarter June 0.57 0.08 0.06 0.11
I Quarter March 0.20 0.05 0.11 0.10
FY   1.00 0.25 0.41 0.29



CATX Capital Expenditures fourth quarter 2023 Y/Y Growth Comment
Perspective Therapeutics Inc in the fourth quarter 2023 recorded Capital Expenditures of $ 0.00 millions.

Looking into fourth quarter 2023 results within Medical Equipment & Supplies industry 47 other companies have achieved higher Capital Expenditures growth. While Perspective Therapeutics Inc ' s Capital Expenditures no change of % ranks overall at the positon no. 1250 in the fourth quarter 2023.




CATX Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -35.71 % 250 % -63.64 %
III Quarter September 666.67 % -70 % 150 % -69.23 %
II Quarter June 612.5 % 33.33 % -45.45 % 0 %
I Quarter March 300 % -54.55 % 10 % -9.09 %
FY   300 % -39.02 % 41.38 % -36.96 %

Financial Statements
Perspective Therapeutics Inc 's fourth quarter 2023 Capital Expenditures $ 0.00 millions CATX's Income Statement
Perspective Therapeutics Inc 's fourth quarter 2022 Capital Expenditures $ 0.09 millions Quarterly CATX's Income Statement
New: More CATX's historic Capital Expenditures Growth >>


CATX Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 200 % 40 % 0 %
III Quarter September -59.65 % -62.5 % 66.67 % -63.64 %
II Quarter June 185 % 60 % -45.45 % 10 %
I Quarter March 122.22 % -64.29 % 175 % -9.09 %
FY (Year on Year)   300 % -39.02 % 41.38 % -36.96 %




Capital Expenditures fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #48
Healthcare Sector #140
Overall #1250

Capital Expenditures Y/Y Growth Statistics
High Average Low
448.28 % 88.34 % -47.87 %
(Dec 31 2016)   (Dec 31 2017)
Capital Expenditures fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #48
Healthcare Sector #140
Overall #1250
Capital Expenditures Y/Y Growth Statistics
High Average Low
448.28 % 88.34 % -47.87 %
(Dec 31 2016)   (Dec 31 2017)

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Perspective Therapeutics Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CATX's IV. Quarter Q/Q Capital Expenditures Comment
IV. Quarter 2023 accomplishment of 0.00 millions by Perspective Therapeutics Inc come out even worse compare to the 0.23 millions a quarter before.

Within Medical Equipment & Supplies industry Perspective Therapeutics Inc achieved highest sequential Capital Expenditures growth. While Perspective Therapeutics Inc 's Capital Expenditures growth quarter on quarter, overall rank is .


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CATX's IV. Quarter Q/Q Capital Expenditures Comment
IV. Quarter 2023 Capital Expenditures of 0.00 millions by Perspective Therapeutics Inc appear even worse compare to the Capital Expenditures 0.23 millions in the third quarter.

Within Medical Equipment & Supplies industry Perspective Therapeutics Inc achieved highest sequential Capital Expenditures growth. While Perspective Therapeutics Inc 's Capital Expenditures growth quarter on quarter, overall rank is .


Perspective Therapeutics Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Sep 30 2022)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 1.09 $ 0.89 $ 0.40 $ 0.25
Y / Y Capital Expenditures Growth (TTM) - 264.88 % 138.61 % 13.07 % -38.93 %
Year on Year Capital Expenditures Growth Overall Ranking # 1494 # 1485 # 645 # 549 # 391
Seqeuential Capital Expenditures Change (TTM) - 22.58 % 123.62 % 58.57 % -16.05 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1339 # 1777 # 1332 # 1089 # 510




Cumulative Capital Expenditures growth Comment
Perspective Therapeutics Inc realized trailing twelve months Capital Expenditures of $ 0 millions, in the Dec 31 2023, compare to Capital Expenditures of $ 0 millions a year ago.

In the Healthcare sector 177 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 1485 to 1494.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
448.28 %
88.34 %
-47.87 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 52
Healthcare Sector # 178
Overall # 1494

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
448.28 %
88.34 %
-47.87 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 52
Sector # 152
S&P 500 # 1339
Cumulative Capital Expenditures growth Comment
Perspective Therapeutics Inc realized trailing twelve months Capital Expenditures of $ 0 millions, in the Dec 31 2023, compare to Capital Expenditures of $ 0 millions a year ago.

In the Healthcare sector 177 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 1485 to 1494.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
448.28 %
88.34 %
-47.87 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 52
Healthcare Sector # 178
Overall # 1494

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
448.28 %
88.34 %
-47.87 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 52
Sector # 152
S&P 500 # 1339




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
CATX's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for CATX's Competitors
Capital Expenditures Growth for Perspective Therapeutics Inc 's Suppliers
Capital Expenditures Growth for CATX's Customers

You may also want to know
CATX's Annual Growth Rates CATX's Profitability Ratios CATX's Asset Turnover Ratio CATX's Dividend Growth
CATX's Roe CATX's Valuation Ratios CATX's Financial Strength Ratios CATX's Dividend Payout Ratio
CATX's Roa CATX's Inventory Turnover Ratio CATX's Growth Rates CATX's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2023
Sunshine Biopharma Inc -0.43%$ -0.431 millions
Infusystem Holdings Inc-0.73%$ -0.730 millions
Stereotaxis Inc -0.81%$ -0.813 millions
Icon Plc-1.03%$ -1.033 millions
Mdxhealth Sa-1.51%$ -1.506 millions
Alpine Immune Sciences Inc -1.72%$ -1.724 millions
Argenx se-2.99%$ -2.987 millions
Abbvie Inc -3.76%$ -3.756 millions
Vanda Pharmaceuticals Inc -3.80%$ -3.802 millions
Warby Parker Inc -4.52%$ -4.516 millions
Bristol myers Squibb Company-4.62%$ -4.624 millions
Baxter International Inc -5.00%$ -5.000 millions
Progyny Inc -5.55%$ -5.548 millions
Precipio inc -5.77%$ -5.769 millions
Koru Medical Systems Inc -6.92%$ -6.916 millions
Ufp Technologies Inc -7.02%$ -7.018 millions
Bio rad Laboratories Inc -7.27%$ -7.272 millions
Endo International Plc-8.13%$ -8.130 millions
Eterna Therapeutics Inc -9.52%$ -9.524 millions
Sotera Health Company-9.63%$ -9.633 millions
Hutchmed china Limited-11.05%$ -11.052 millions
Biolinerx Ltd -11.45%$ -11.450 millions
Petvivo Holdings Inc-11.46%$ -11.461 millions
Novartis Ag-11.52%$ -11.519 millions
Charles River Laboratories International inc -12.02%$ -12.020 millions
Surgery Partners Inc -12.78%$ -12.775 millions
Xbiotech Inc -12.88%$ -12.879 millions
Cardiol Therapeutics inc -13.92%$ -13.917 millions
Merck and Co Inc -13.93%$ -13.925 millions
Conmed Corporation-14.46%$ -14.464 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com